18 November 2013 - Deborah Wilkes
Archived
Chile's CFR Pharmaceuticals has now made a firm offer to purchase South Africa's Adcock Ingram in a cash and share deal worth ZAR12.6 billion (US$1.30 billion). The news follows weeks of speculation about shareholder support for the proposed deal and possible competing bids.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.